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Abstract  
Background 
Non-motor symptoms (NMS) are common in Parkinson’s disease (PD) and cause significant 
distress. A high rate of non-declaration of NMS by patients to healthcare providers (HCP) 
means that many NMS remain untreated. Current understanding of the factors preventing 
disclosure of NMS to HCPs is limited. The present study aimed to i) further assess the 
prevalence of NMS and associated distress, ii) establish current rates of NMS reporting 
across a range of sources, and iii) explore overall and any symptom specific barriers to help-
seeking for NMS.  
Methods 
358 PD patients completed a cross-sectional survey of NMS severity, reporting and barriers 
to help-seeking.  A series of Generalised Estimating Equations were used to determine 
whether barriers were symptom specific. 
Results 
A mean of 10.5 NMS were reported by each patient. Rates of non-reporting of NMS ranged 
from 15-72% of those experiencing distressing symptoms. The most commonly reported 
barriers to help-seeking were acceptance of symptoms; lack of awareness that a symptom 
was associated with PD, and belief that no effective treatments were available. Symptom 
specific barriers were found for sexual dysfunction (embarrassment), unexplained pain and 
urinary problems (belief about lack of treatment availability).  
Conclusion 
A diverse range of barriers prevent PD patients reporting NMS to HCPs and these barriers 
differ between NMS. The study provides the foundations for developing interventions to 
increase reporting by targeting individual NMS. Increasing rates of help-seeking for NMS by 
patients to their Parkinson’s healthcare providers will increase appropriate clinical care 
which may improve quality of life and well-being. 
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Introduction 
Non-motor symptoms (NMS) of Parkinson’s disease (PD) are common and problematic. Up 
to 98% of people with Parkinson’s report experiencing at least one NMS [1-3]. Several 
studies have demonstrated the negative impact of NMS on patient quality of life (QoL) and 
psychological well-being which is often found to be greater than the impact attributable to 
motor symptoms [4-8]. Mood symptoms, urinary symptoms, fatigue and leg pain are 
amongst the most commonly reported NMS [1-3]. Other common symptoms include 
unexplained pain, bowel problems, sleep problems and issues with memory and 
concentration. 
The issue of non-reporting of NMS by patients to clinicians has been highlighted by 
Chaudhuri et al. [9, 10]. In a large scale European survey they found that in some cases over 
50% of patients experiencing NMS did not report them to a healthcare provider (HCP). 
Despite several reviews outlining potentially efficacious treatments for a range of NMS [11-
16], they are still not routinely screened for, even in specialist centres [9]. This failure to 
screen for NMS combined with a lack of reporting by patients results in distressing 
symptoms remaining untreated.  
Preliminary research based on a single question ‘why have you not told your healthcare 
provider’ in response to self-reported NMS [10] highlighted a range of potential barriers. 
These barriers included lack of awareness that symptoms were related to PD, 
embarrassment at discussing symptoms, and limited time in consultations for discussing 
non-motor issues. More recently a theoretically driven qualitative study explored the 
complexity of barriers to help-seeking for NMS in more depth [17]. A total of 23 individual 
barriers to help-seeking for a range of NMS were identified. Uncertainty about the link 
between NMS and PD, and lack of clarity around the availability of treatments were 
common barriers to reporting a range of NMS. However some barriers appeared to be 
symptom specific. For example embarrassment and communication difficulties were 
common for potentially sensitive symptoms such as sexual dysfunction, bowel and bladder 
problems.  
Several questions remain to be answered if we are to improve our understanding of the 
factors which prevent patients reporting NMS to their HCP and consequently, how we might 
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overcome these challenges. The complex range of barriers to help-seeking identified by Hurt 
et al [17] need to be validated in a larger sample of people experiencing undeclared NMS to 
ascertain their generalisability to all people with Parkinson’s. It remains unclear whether 
barriers to symptom reporting are patient related or if barriers are symptom specific.   
The aims of the present study were three fold: i) to further assess the prevalence of NMS 
and associated levels of distress, ii) to establish current rates of NMS reporting across a 
range of formal and informal sources, and iii) to explore overall and any symptom specific 
barriers to help-seeking for NMS.  
 
Methods 
Design 
Data on presence of non-motor symptoms, help-seeking behaviour and barriers to help-
seeking was collected in a large-scale cross-sectional survey. Data were collected using an 
online survey tool (Survey Monkey) [18], and using paper-based questionnaires. Data 
collection took place between March 2015 and August 2015. Ethical approval was granted by 
Cornwall and Plymouth Research Ethics Committee (ref:14/SW/0099). 
 
Measures  
The NMSQuest [1] which consists of 30 common NMS, was used to assess the presence of 
NMS. For the purpose of the present study the item ‘altered interest in sex’ was replaced by 
two items,  ‘increased’ and ‘decreased’ interest giving a total of 31 items. For each symptom 
reported as present over the past 12 months, the participant was asked to rate how 
distressing the symptom was from 0 (not at all) to 3 (severely distressing). They were also 
asked if they had sought help for the symptom and, if so, from whom using a pre-defined list 
of sources of help whom patients with Parkinson’s have regular contact (Formal sources: 
Consultant (senior doctor), Parkinson’s Nurse Specialist and General Practitioner; Informal 
sources: Pharmacist, friends and family). Within the UK National Health Service patients with 
Parkinson’s may receive management of their PD from a range of sources most commonly a 
Consultant Neurologist (a senior doctor specialising in movement disorders) or a Consultant 
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Geriatrician (a senior doctor specialising in care of older adults). Many patients not requiring 
complex management are treated by their General Practitioner in primary care. All patients 
should have access to a Parkinson’s Disease Specialist Nurse (a nurse trained and specialising 
in the management of PD). Those experiencing distressing symptoms who had not sought 
help from an HCP were asked to endorse any and all relevant barriers from a pre-defined list 
based on the findings of Hurt et al. [17] (The full list of barriers is available in the 
supplementary materials, Table S1) . A self-report measure of impairment of activities of daily 
living associated with PD, the Parkinson’s Activities of Daily Living Scale (PADL) [19] was used 
as a proxy for disease severity. Clinical and demographic data were collected for all 
participants (see Table 1).  
Participants 
Participants were recruited via the Parkinson’s UK Research Support Network and neurology 
outpatient clinics across south London, UK. All participants had the option of completing an 
online or paper questionnaire. To provide a broad and inclusive sample no eligibility criteria 
were set beyond a clinical diagnosis of Parkinson’s disease, ability to give informed consent 
and complete the study questionnaires. 
Sample size and statistical analysis 
Categorical data on presence/absence of each barrier were collected from each patient for 
all reported symptoms. Data were modelled to compare the distribution of barriers across 
different NMS. Logistic Generalised Estimating Equation (GEE) Models were run for each 
barrier separately, with the binary indicator variable for presence of barrier as the outcome, 
and the 31 indicator variables for symptoms as explanatory variables. This model allowed us 
to assess the difference in the probability of choosing the barrier by comparing symptom 2 to 
symptom 1, and symptom 3 to symptom 1, etc.  As a general rule, an average sample size of 
at least 300 is required for a maximum of 30 parameters (symptoms). For each model we 
selected symptoms where at least 1 person reported the barrier as a reason for not reporting 
a symptom  
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Results 
A total of 358 participants were recruited (206 via Parkinson’s UK, 150 from NHS trusts and 2 
from other sources). 159 paper questionnaires were completed and the remaining 199 
questionnaires were completed online. The sample characteristics are shown in table 1. 
Table 1 here  
 
Frequency of Non-Motor Symptoms 
The frequency of NMS reported by the sample and the associated levels of distress are shown 
in figure 1, with symptoms ranked from most to least frequent.  In line with previous research, 
urinary symptoms were the most commonly experienced NMS and delusions the least 
common.  Bowel incontinence, unexplained pain and falling due to fainting/blacking out were 
identified as the most likely to be associated with significant distress when present, while 
swallowing/choking, nausea/vomiting and dribbling were rated least likely to cause distress. 
Overall the proportion of participants rating their NMS as moderately or severely distressing 
ranged from 16.4% to 58.9%.  
Figure 1 here 
The mean number of NMS experienced by each patient over the previous 12 months was 10.5 
(SD=5.4, range=0-25).  NMS burden was calculated using the cut-offs provided by Chaudhuri 
et al. [20]. Only four of the 358 participants had no NMS (1.1%), 18.4% reported 1-5 NMS 
(mild burden), 27.7% reported 6-9 symptoms (moderate burden), 26% reported 10-13 
symptoms (severe burden) and 26.8% reported greater than 13 NMS representing very severe 
burden. 
 
Help-seeking for NMS  
The frequency of declaration of NMS to a range of formal and informal sources is shown in 
table 2. For 22 of the 31 symptoms at least 30% of participants who described experiencing 
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distressing NMS had not reported them to an HCP. ‘Loss of interest in sex’ was the least 
reported NMS with only 28% of patients telling their HCP, although the figure rose to 48% 
when informal sources of help were included.  Falling due to fainting or blacking out had the 
highest reporting rate to an HCP with 85% of patients experiencing the symptom reporting it, 
rising to 92% when informal sources of help were included. A large proportion of patients 
reported their NMS to a family member or friend, even when not reporting them to an HCP. 
For 25 of the 31 NMS the PD nurse was the HCP that symptoms were most commonly 
reported to.  
Table 2 here 
 
Barriers to reporting NMS 
Barriers to help-seeking were recorded for those with distressing NMS who had not reported 
their symptoms to an HCP. Eighteen barriers to help-seeking were endorsed by one or more 
participants (range 10 – 292), with 8 barriers endorsed by 100 participants or more. These 
included ‘Acceptance of the symptom as part of life’ (n=292), ‘Uncertainty that effective 
treatment is available’ (n=222), ‘Uncertainty whether the symptom is part of PD’ (n=206), 
‘Belief that the symptom is not serious’ (n=156), ‘Concern that treatment will require change 
of PD medication or taking extra medication’ (n=125), ‘Not a priority at the time’ (n=114), 
‘Belief that raising the problem not socially acceptable’ (n=108), and ‘Lack of priority to NMS 
in the consultation’ (n=108). A series of chi-squared tests were run to compare barrier 
reporting between males and females. No significant differences found at p<.05.  
A full break down of barrier frequency is given in the supplementary information (Table S2).  
As no barriers to reporting delusions were endorsed this symptom was excluded from further 
analyses. Additionally, due to the small number of participants reporting the barrier ‘speaking 
to an HCP of the same gender’ (N=10) this barrier was excluded from further analyses.  
A series of GEEs were used to determine whether certain barriers to help-seeking were 
associated with specific symptoms. Inferential statistics for the barriers found to have 
statistically significant associations with specific NMS are presented in table 3. The full 
inferential statistics for all models are available from the authors on request.  
8 
 
Symptoms relating to sexual function were associated with embarrassment and being difficult 
to talk about. Urinary urgency and unexplained pain were associated with acceptance, were 
not associated with PD and not perceived as treatable.  
Table 3 here 
 
Discussion 
The NMS frequencies found in the present study are in line with previous research using the 
NMSQuest [1-3]. The high mean number of NMS reported by each participant over a 12 
month period (10.5) reinforces the importance of identifying and treating these symptoms to 
improve patient QoL and well-being.   
Failure to disclose NMS to HCPs has been previously documented [10] and similarly high rates 
of non-disclosure were found in the present study. However, this research is the first to 
provide an in-depth analysis of NMS reporting to both formal and informal sources. A number 
of significant findings emerged. Firstly, participants were likely to have discussed their 
symptom with a friend or family member even if they had not discussed it with an HCP. This 
highlights the importance of providing family members and carers with good quality 
information about NMS, available treatments and services. Recent research identified patient 
and carer dissatisfaction with the quality of information and explanation of NMS during 
consultations with HCPs [21]. This suggests an urgent need to provide educational resources 
for both patients and caregivers. 
Secondly, for the majority of symptoms the largest proportion of patients reported NMS to 
their PD nurse rather than any other HCP. While it is positive that patients are reporting to an 
HCP with specialist PD knowledge, those without regular access to a PD nurse might be at 
greatest risk of having undisclosed NMS [22]. Gaps in PD nurse service provision are not 
confined to the UK and are apparent across a range of countries indicating the potentially 
global nature of the problem [23-25]. The larger proportion of patients reporting NMS to their 
PD nurse than their consultant could be attributable to a range of factors: it may reflect ease 
of access to PD nurses comparative to consultants, patients may feel more confident to 
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discuss NMS with a specialist nurse or there may simply be more time available during 
appointments with PD nurses for discussion of a range of concerns.  
A range of barriers to reporting NMS were endorsed with the most common being accepting 
the symptom as part of everyday life, not associating the symptom with PD and believing that 
no effective treatments were available. Significant associations were found between barriers 
to symptom reporting and individual NMS suggesting that the type of barrier preventing 
reporting may be specific to the symptom. Interestingly no gender differences were found in 
barriers to symptom reporting. Due to the predominantly white British sample we were 
unable to explore the effect of ethnicity on help-seeking and the associated barriers. Ethnicity 
is likely to play a significant role in symptom reporting for a variety of reasons including 
language and cultural barriers [26]. Future research is required to explore these barriers.    
The findings of the present research suggest that any interventions aimed at increasing help-
seeking for non-motor symptoms may be most effective if different strategies were used to 
target individual NMS. For example the use of normalising information and reassurance about 
asking for help may be helpful for patients experiencing sexual dysfunction. Normalising 
information and reassurance have increased help-seeking intentions for gynaecological 
cancer symptoms where embarrassment also acts as a barrier to accessing care [27].    
Information about NMS and available treatment options may be more effective in 
encouraging help-seeking for unexplained pain and urinary symptoms. Supporting patients to 
consider the pros and cons of reporting symptoms they have ‘accepted as part of life’, such 
as constipation, excessive sweating and insomnia, may encourage help-seeking. Pros and cons 
exercises are commonly used in Cognitive Behaviour Therapy to help patients consider all 
perspectives and outcomes before making decisions [28]. This exercise may illustrate that 
reporting symptoms is relatively low cost and has the potential to lead to significant 
improvements in quality of life through appropriate symptom management.   
Also notable from the study was the significant proportion of participants reporting moderate 
or low levels of distress. While this may link to symptom frequency or severity, it may also be 
associated with protective psychological factors. One of these may be acceptance. While 
acceptance of the symptom as part of PD emerged as a barrier to help seeking in those with 
distressing symptoms, it can be a positive adaptation in those living with a chronic condition 
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where no symptomatic treatment is available. Evidence supports an association with better 
health outcomes (lower levels of depression and increased health related quality of life) in 
conditions such as chronic pain[29]. In the present study, low levels of distress associated with 
a symptom in some participants may relate to a positive adjustment to the presence of the 
symptoms. However, while such acceptance may be a positive or protective psychological 
factor for some, it still presents a barrier to help seeking when the symptom is treatable. 
Indeed for all but three NMS explored in this study 100% of participants endorsing acceptance 
as a barrier to help-seeking were experiencing moderate to severely distressing NMS. This 
suggests that in the present sample acceptance acted as a barrier rather than psychologically 
protective factor.  
The study explored a wide range of symptoms which are all known to be non-motor 
symptoms of PD. However we cannot say definitively that these symptoms are associated 
with PD rather than other co-morbid conditions. Regardless of aetiology the sample reported 
experiencing untreated distressing symptoms. Encouraging and supporting patients to report 
these symptoms should enable them to receive appropriate management and potentially 
reduce distress and improve well-being whatever their cause.   
The present study is not without limitations. The sample was recruited via two methods, 
outpatient clinics and the Parkinson’s UK Research Network. The latter consists of people 
diagnosed with PD who have actively opted to participate in research projects. It is likely that 
these patients are proactive and knowledgeable about their condition which may have led to 
a lower rate of non-disclosure than may be seen in a broader outpatient clinic sample. The 
NMSQuest item ‘altered interest in sex’ covers both loss of interest in sex and hypersexuality.  
Barriers preventing help-seeking are likely to vary between these two symptoms, for example 
loss of interest in sex may be associated with increasing age but it seems unlikely that 
hypersexuality would be attributed to aging. Consequently to achieve the aims of the present 
study it was necessary to subdivide this item. However the NMSQuest was developed as an 
evaluation and not a discriminant tool [1] and consequently issues of validity and reliability 
are not relevant here. The barriers list was developed from qualitative research by Hurt et al. 
[17].  It was designed as a checklist rather than a quantitative scale and consequently no 
assessment of the validity and reliability was undertaken. 
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Despite these limitations the findings do highlight the prevalence and burden of NMS and the 
high rates of non-disclosure. The identification of common barriers to symptom reporting 
provides a basis from which to develop much needed interventions to encourage patients 
with untreated, distressing NMS to report them to their HCP. Increased NMS reporting should 
lead to receipt of appropriate clinical care potentially improving well-being and quality of life.  
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Table 1. Sample Characteristics (N=358) 
Characteristic Mean/N Range/Percentage 
Age 66.3 years 51-83 years 
Gender   
Male 186 52.5% 
Female 168 47.5% 
PD duration 5.9 years 1-33 years 
PADL 2.3 1-5 
Employment status   
Full-time 45 12.6% 
Part-time 25 7% 
Unemployed 10 2.8% 
Retired 228 63.9% 
Retired due to health 49 13.7% 
   
Education    
Left school before 15 42 11.9% 
GCSE or equivalent level 76 21.5% 
A-levels or equivalent 56 15.8% 
University level 180 50.9% 
Ethnicity   
White 323 90.7 % 
Asian/Asian British 17 4.8 % 
Black/African/Caribbean/Black 
British 
10 2.8 % 
Other 6 1.7 % 
   
Marital status   
Married/civil 
partnership/cohabiting 
277 77.4% 
Widowed 29 8.1% 
Single (never married) 28 7.8% 
Divorced/separated 19 5.3% 
Other 5 1.4% 
Primary PD HCP   
GP 24 6.8% 
Consultant Neurologist 253 72.1% 
Consultant Geriatrician 14 4.0% 
PD Nurse 57 16.2% 
Other  3 0.9% 
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Figure 1. Frequency of NMS and associated level of distress across total sample (N=358) 
  
Symptoms are ranked by prevalence from high to low. No distress rating = symptom was endorsed but distress data missing. 
0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0
Delusions
Increased interest in sex
Bowel incontinence
Double vision
Hallucinations
Vomiting/nausea
Excessive sweating
Change in weight
Swelling in the legs
Daytime sleepiness
Falling due to fainting/blacking out
Loss of interest
Difficulty having sex
Loss of interest in sex
Swallowing or choking
Acting out dreams
Vivid dreams
Dribbling
Incomplete bowel emptying
Difficulty concentrating
Change in taste and smell
Dizziness
Feeling anxious
Unexplained pain
Insomnia
Constipation
Feeling low
Restless legs
Forgetting
Nocturia
Urinary urgency
No distress rating (%) No distress (%) Mild distress (%) Moderate distress (%) severe distress (%)
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Table 2. Declaration of NMS by source of help 
*HCP = GP, PD nurse or consultant 
Italics = HCP the largest proportion of patients reported symptoms to 
NMS Not reported 
at anyone % 
Consultant 
% 
PD Nurse 
% 
GP % Pharmacist 
% 
Friend or 
family % 
Not reported 
to HCP* % 
Urinary urgency 20.3 31.6 54.5 37.7 6.1 42 29.0 
Nocturia 21.8 32 53.3 35.1 4.9 41.3 29.8 
Forgetting 18.0 35.4 48.9 26.4 6.7 53.9 37.1 
Restless legs 21.6 34.1 54 24.4 4.5 50 32.4 
Feeling low 25.6 31.3 44.9 30.1 7.4 52.8 40.9 
Constipation 14.9 34.9 55.4 42.3 6.9 34.3 22.3 
Insomnia 12.3 45 60.2 35.1 6.4 54.4 22.2 
Unexplained pain  16.7 39.3 48.8 43.5 7.1 48.2 29.8 
Feeling anxious 24.2 31.2 53.5 28.7 7 48.4 35.0 
Dizziness 24.2 32.2 47 33.6 7.4 49 34.9 
Change in taste and 
smell 
25.9 36.1 44.9 21.8 4.1 42.9 39.5 
Difficulty 
concentrating 
23.8 31.5 47.6 27.3 7 46.9 42.0 
Incomplete bowel 
emptying 
44.4 19.7 40.1 27.5 7 23.9 48.6 
Dribbling 32.8 28.9 46.9 20.3 3.1 31.1 39.1 
Vivid dreams 15.6 41.8 57.4 24.6 4.9 62.3 31.1 
Acting out dreams 14.7 32.8 54.3 24.1 6 62.9 32.8 
Swallowing or 
choking 
21.6 31 56.9 21.6 6 46.6 37.1 
Loss of interest in 
sex 
52.3 11.7 13.5 16.2 1.8 31.5 72.1 
Difficulty having sex 44.3 15.1 15.1 31.1 2.8 34 58.5 
Loss of interest 33.7 24 45.2 20.2 4.8 42.3 47.1 
Falling due to 
fainting/blacking out 
8.0 53 65 53 10 64 15.0 
Daytime sleepiness 12.6 37.9 57.5 25.3 11.5 57.5 24.1 
Swelling in the legs 16.3 29.1 41.9 53.5 2.3 50 25.6 
Change in weight 22.2 35.8 40.7 44.4 4.9 46.9 29.6 
Excessive sweating 27.8 35.4 41.8 34.2 5.1 44.3 43.0 
Vomiting/Nausea 25.4 32.8 38.8 29.9 6 43.3 41.8 
Hallucinations 16.4 49.1 52.7 16.2 7.3 43.6 27.3 
Double vision 25.5 41.2 41.2 49 9.8 41.2 35.3 
Bowel incontinence 17.8 33.3 48.9 42.2 6.7 42.2 26.7 
Increased interest in 
sex 
43.9 14.6 22 24.4 2.4 29.3 58.5 
Delusions 8.7 39.1 60.9 39.1 17.4 56.5 26.1 
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Table 3. Generalised estimating equations for barriers to help-seeking for non-motor symptoms (only significant associations shown, p<0.05) 
Barrier / NMS Odds Ratio Confidence interval 
Wald Chi-
Square p-value 
 
Odds Ratio Confidence interval 
Wald Chi-
Square P-value 
        
Barrier Uncertainty whether the symptom is part of PD  Belief that the symptom is not serious 
 Urinary Urgency .342 .137 .851 5.325 .021  - - - - - 
 Unexplained Pain .125 .055 .284 24.662 <.001  .237 .098 .576 10.09 .001 
            
Barrier Belief that self-help strategies are a preferable or acceptable 
option 
 Belief that raising the problem is not socially acceptable 
 Unexplained Pain - - - - -  .258 .089 .747 6.248 .012 
 Constipation .278 .090 .860 4.930 .026  - - - - - 
            
Barrier A perception of the symptom as embarrassing   Communication skills   
 Urinary urgency - - - - -  .123 .015 .990 3.878 .049 
 Lower libido .177 .039 .811 4.970 .026  .074 .010 .574 6.207 .013 
 Difficulty having sex .149 .033 .671 6.155 .013  .064 .008 .490 7.004 .008 
            
Barrier Acceptance of the symptom as ‘part of life’   Uncertainty that effective treatment is available 
 Dribbling - - - - -  6.085 1.012 36.602 3.891 .049 
 Taste and smell .109 .014 .866 4.390 .036  - - - - - 
 Constipation .064 .008 .490 7.004 .008  - - - - - 
 Bowel emptying .069 .009 .529 6.613 .010  - - - - - 
 Urinary urgency .036 .005 .267 10.562 .001  .364 .146 .911 4.661 .031 
 Nocturia .060 .008 .456 7.380 .007  - - - - - 
 Unexplained pain .027 .004 .197 12.606 <.001  .193 .083 .452 14.378 <.001 
 Forgetting .097 .012 .770 4.877 .027  - - - - - 
 Sad .069 .009 .529 6.613 .010  - - - - - 
 Difficulty having sex .047 .006 .357 8.764 .003  .390 .155 .980 4.009 .045 
 Dizzy from standing .097 .012 .770 4.877 .027  - - - - - 
 Insomnia .081 .010 .628 5.783 .016  - - - - - 
 Excessive sweating .123 .015 .990 3.878 .049  - - - - - 
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Supplementary Files 
Table S1. Potential Barriers to Reporting Non-Motor Symptoms to an Healthcare Professional 
Barriers to NMS Reporting Participant barrier list 
Uncertainty whether the symptom is part of PD ‘I am unsure whether this symptom is related to Parkinson's Disease’ 
Belief that the symptom is not serious ‘The symptom is not serious enough to report it’ 
Acceptance of the symptom as ‘part of life’ ‘I have accepted the symptom as part of my everyday life’  
Belief that self-help strategies are a preferable or acceptable option ‘I do not report the symptom because there are things that I can do to control the symptom myself’ 
Uncertainty that effective treatment is available ‘I am not sure if anything can be done about my symptom’ 
Communication skills ‘I find it difficult to talk about my symptom’ 
Concern that treatment will require change of PD medication or 
taking extra medication 
‘I don't want to increase my medication dose or treatment’ 
Not a priority at the time ‘The priority for reporting this symptom is either low or is lower than the other symptoms or problems that I 
am experiencing at the time when I see my doctor’ 
Lack of energy ‘I don't have the energy to discuss all of my symptoms’ 
Problems with memory and concentration ‘I forget or get side tracked’ 
21 
 
Presence of another non-HCP ‘Having someone in the consultation room with me stops me reporting my symptom’ 
A perception of the symptom as embarrassing ‘Asking for help with this symptom would be embarrassing’ 
Belief that raising the problem is not socially acceptable ‘I feel I would be making a fuss’ 
Lack of rapport with the HCP ‘I don't have a good rapport with my doctor’ 
Lack of time in the consultation ‘There is a lack of time during consultations’ 
Preference to talk to a different HCP (familiarity/availability) ‘I would rather talk to someone I know about this symptom’ 
Preference to talk to an HCP of the same gender ‘I would rather talk to someone of the same gender about this symptom’ 
Lack of priority to NMS in the consultation ‘The consultation focus on the main symptoms of Parkinson’s and this is not one of the main symptoms’ 
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Table S2. Frequency of barriers to reporting Non-motor Symptoms to a healthcare provider  
  
Uncert
ainty 
wheth
er the 
sympto
m is 
part of 
PD 
Belief 
that 
the 
sympto
m is 
not 
serious 
Accept
ance of 
the 
sympto
m as 
‘part of 
life’ 
Belief 
that 
self-
help 
strateg
ies are 
a 
prefera
ble or 
accept
able 
option 
Uncert
ainty 
that 
effectiv
e 
treatm
ent is 
availab
le 
Comm
unicati
on 
skills 
Concer
n that 
treatm
ent will 
require 
change 
of PD 
medica
tion or 
taking 
extra 
medica
tion 
Not a 
priority 
at the 
time 
Lack of 
energy 
Proble
ms 
with 
memor
y and 
concen
tration 
Presen
ce of 
anothe
r non-
HCP 
A 
percep
tion of 
the 
sympto
m as 
embarr
assing 
Belief 
that 
raising 
the 
proble
m not 
socially 
accept
able 
Lack of 
rappor
t with 
HCP 
Lack of 
time 
Prefere
nce to 
talk to 
differe
nt HCP 
(familia
rity/av
ailabilit
y) 
Prefere
nce to 
talk to 
HCP of 
the 
same 
gender 
Lack of 
priority 
to NMS 
in the 
consult
ation 
Total freq. 
of Barrier 206 156 292 99 222 74 125 114 42 57 21 51 108 23 37 37 10 108 
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